A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID‐19) pandemic: an international collaborative group

HO Al‐Shamsi, W Alhazzani, A Alhuraiji… - The …, 2020 - academic.oup.com
The outbreak of coronavirus disease 2019 (COVID‐19) has rapidly spread globally since
being identified as a public health emergency of major international concern and has now …

COVID-19 and cancer: a comprehensive review

R Gosain, Y Abdou, A Singh, N Rana, I Puzanov… - Current oncology …, 2020 - Springer
Abstract Purpose of Review The outbreak of the novel coronavirus disease 2019 (COVID-
19) has emerged to be the biggest global health threat worldwide, which has now infected …

Molecular and kinetic analyses of circulating tumor cells as predictive markers of treatment response in locally advanced rectal cancer patients

BC Troncarelli Flores, V Souza e Silva, E Ali Abdallah… - Cells, 2019 - mdpi.com
Neoadjuvant chemoradiation (NCRT) followed by total mesorectal excision is the standard
treatment for locally advanced rectal cancer (LARC). To justify a non-surgical approach …

Особенности ведения онкологических пациентов во время пандемии коронавирусной инфекции COVID-19

МИ Секачева, АС Русанов, АС Фатьянова… - Сеченовский …, 2020 - cyberleninka.ru
Новая коронавирусная инфекция, вызывающая COVID-19, на сегодня не в полной мере
поддается должному контролю. В периодических изданиях часто появляются …

Capecitabine versus continuous infusion fluorouracil for the treatment of advanced or metastatic colorectal cancer: a meta-analysis

Z Wu, Y Deng - Current Treatment Options in Oncology, 2018 - Springer
Opinion statement Nowadays, systemic chemotherapy with intravenous (IV) 5-fluorouracil (5-
FU) remains the most commonly prescribed treatment for metastatic colorectal cancers …

A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors

M Joerger, A Stathis, Y Metaxas, D Hess… - Investigational new …, 2020 - Springer
Purpose BAL101553, the prodrug of the microtubule-destabilizer BAL27862, previously
showed signs of antitumor activity when administered as a 2-h infusion, but its use was …

Adding consolidation capecitabine to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a propensity-matched comparative study

Y Fang, C Sheng, F Ding, W Zhao, G Guan… - Frontiers in Surgery, 2022 - frontiersin.org
Aim To determine whether adding consolidation capecitabine chemotherapy without
lengthening the waiting period influences pathological complete response (pCR) and short …

The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta‐analysis

X Zhong, Z Wu, P Gao, J Shi, J Sun, Z Guo… - Cancer …, 2018 - Wiley Online Library
Patients with locally advanced rectal cancer (LARC) are at tremendous risk of metastatic
diseases. To improve the prognoses of LARC patients, the efficacy of adding targeted …

Рак во время пандемии коронавирусной инфекции COVID-19

ШХ Ганцев, РА Рустамханов - Медицинский вестник …, 2020 - cyberleninka.ru
Новый коронавирус, также известный как SARS-Cov-2 или COVID-19, стал всемирной
угрозой и серьезной проблемой здравоохранения в 2020 году. Возникновение этого …

[PDF][PDF] Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally …

A Paszt, A Ottlakan, S Abraham, Z Simonka… - Pathology and …, 2022 - por-journal.com
Background: During the last decade, one of the most important treatment options for locally
advanced, potencially resectable rectal tumours was neoadjuvant chemoradiotherapy (CRT) …